3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Status
Terminated
2
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Thoracic
2
Conditions
Carcinoma, Non-Small-Cell Lung
25
Squamous Cell Carcinoma of Head and Neck
10
Lung Neoplasms
10
Neoplasms
6
Neoplasm Metastasis
6
Head and Neck Neoplasms
6
Esophageal Squamous Cell Carcinoma
5
Breast Neoplasms
5
Pancreatic Neoplasms
4
Carcinoma, Squamous Cell
4
Stomach Neoplasms
3
Esophageal Neoplasms
3
Brain Neoplasms
3
Prostatic Neoplasms
2
Non-small-cell Lung Cancer With Somatic EGFR Mutations
2
NSCLC
2
Glioblastoma
2
Colorectal Neoplasms
2
Adenocarcinoma of Lung
2
Urinary Bladder Neoplasms
1
Urethral Neoplasms
1
Ureteral Neoplasms
1
Unilateral HER2 Positive Breast Cancer
1
Triple Negative Breast Neoplasms
1
Thrombocytosis
1
Thoracic Neoplasms
1
Squamous Cell Cancers of the Head and Neck
1
Solid Tumors
1
Small Cell Lung Carcinoma
1
Skin Neoplasms
1
Interventions
Pemetrexed
2
Afatinib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
OTHER
×
Non-small-cell Lung Cancer With Somatic EGFR Mutations
×
Afatinib
×
Clear all
NCT02595840
2019-04-19
Trans-MARBLE
Universität Duisburg-Essen
Phase 2
Terminated
4 enrolled
NCT02488694
2018-01-09
MARBLE
AIO-Studien-gGmbH
Phase 2
Terminated
4 enrolled